Challenge infection model for MERS-CoV based on naturally infected camels

Abstract Background Middle East Respiratory Syndrome coronavirus (MERS-CoV) is an emerging virus that infects humans and camels with no approved antiviral therapy or vaccine. Some vaccines are in development for camels as a one-health intervention where vaccinating camels is proposed to reduce human...

Full description

Bibliographic Details
Main Authors: Naif Khalaf Alharbi, Osman H. Ibrahim, Ali Alhafufi, Samy Kasem, Ali Aldowerij, Raed Albrahim, Ali Abu-obaidah, Ali Alkarar, Faisal Altaib Bayoumi, Ali Mohammed Almansour, Musaad Aldubaib, Hail M. Al-Abdely, Hanan H. Balkhy, Ibrahim Qasim
Format: Article
Language:English
Published: BMC 2020-06-01
Series:Virology Journal
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12985-020-01347-5
_version_ 1818417211594768384
author Naif Khalaf Alharbi
Osman H. Ibrahim
Ali Alhafufi
Samy Kasem
Ali Aldowerij
Raed Albrahim
Ali Abu-obaidah
Ali Alkarar
Faisal Altaib Bayoumi
Ali Mohammed Almansour
Musaad Aldubaib
Hail M. Al-Abdely
Hanan H. Balkhy
Ibrahim Qasim
author_facet Naif Khalaf Alharbi
Osman H. Ibrahim
Ali Alhafufi
Samy Kasem
Ali Aldowerij
Raed Albrahim
Ali Abu-obaidah
Ali Alkarar
Faisal Altaib Bayoumi
Ali Mohammed Almansour
Musaad Aldubaib
Hail M. Al-Abdely
Hanan H. Balkhy
Ibrahim Qasim
author_sort Naif Khalaf Alharbi
collection DOAJ
description Abstract Background Middle East Respiratory Syndrome coronavirus (MERS-CoV) is an emerging virus that infects humans and camels with no approved antiviral therapy or vaccine. Some vaccines are in development for camels as a one-health intervention where vaccinating camels is proposed to reduce human viral exposure. This intervention will require an understanding of the prior exposure of camels to the virus and appropriate vaccine efficacy studies in camels. Methods We conducted a cross sectional seroprevalence study in young dromedary camels to determine the rate of MERS-CoV seropositivity in young camels. Next, we utilised naturally infected camels as a natural challenge model that can be used by co-housing these camels with healthy naive camels in a ratio of 1 to 2. This model is aimed to support studies on natural virus transmission as well as evaluating drug and vaccine efficacy. Results We found that 90% of the screened camels have pre-existing antibodies for MERS-CoV. In addition, the challenge model resulted in MERS-CoV transmission within 48 h with infections that continued for 14 days post challenge. Conclusions Our finding suggests that the majority of young dromedary camels in Saudi Arabia are seropositive and that naturally infected camels can serve as a challenge model to assess transmission, therapeutics, and vaccine efficacy.
first_indexed 2024-12-14T12:03:11Z
format Article
id doaj.art-7d42c3225e5e45f3a54ec954440aebd4
institution Directory Open Access Journal
issn 1743-422X
language English
last_indexed 2024-12-14T12:03:11Z
publishDate 2020-06-01
publisher BMC
record_format Article
series Virology Journal
spelling doaj.art-7d42c3225e5e45f3a54ec954440aebd42022-12-21T23:01:56ZengBMCVirology Journal1743-422X2020-06-011711710.1186/s12985-020-01347-5Challenge infection model for MERS-CoV based on naturally infected camelsNaif Khalaf Alharbi0Osman H. Ibrahim1Ali Alhafufi2Samy Kasem3Ali Aldowerij4Raed Albrahim5Ali Abu-obaidah6Ali Alkarar7Faisal Altaib Bayoumi8Ali Mohammed Almansour9Musaad Aldubaib10Hail M. Al-Abdely11Hanan H. Balkhy12Ibrahim Qasim13Department of Infectious Disease Research, King Abdullah International Medical Research CenterMinistry of Environment, Water and Agriculture (MEWA)Ministry of Environment, Water and Agriculture (MEWA)Ministry of Environment, Water and Agriculture (MEWA)Ministry of Environment, Water and Agriculture (MEWA)Ministry of Environment, Water and Agriculture (MEWA)Ministry of Environment, Water and Agriculture (MEWA)Ministry of Environment, Water and Agriculture (MEWA)Ministry of Environment, Water and Agriculture (MEWA)Ministry of Environment, Water and Agriculture (MEWA)College of Agriculture and Veterinary Medicine, Qassim UniversityMinistry of HealthDepartment of Infectious Disease Research, King Abdullah International Medical Research CenterMinistry of Environment, Water and Agriculture (MEWA)Abstract Background Middle East Respiratory Syndrome coronavirus (MERS-CoV) is an emerging virus that infects humans and camels with no approved antiviral therapy or vaccine. Some vaccines are in development for camels as a one-health intervention where vaccinating camels is proposed to reduce human viral exposure. This intervention will require an understanding of the prior exposure of camels to the virus and appropriate vaccine efficacy studies in camels. Methods We conducted a cross sectional seroprevalence study in young dromedary camels to determine the rate of MERS-CoV seropositivity in young camels. Next, we utilised naturally infected camels as a natural challenge model that can be used by co-housing these camels with healthy naive camels in a ratio of 1 to 2. This model is aimed to support studies on natural virus transmission as well as evaluating drug and vaccine efficacy. Results We found that 90% of the screened camels have pre-existing antibodies for MERS-CoV. In addition, the challenge model resulted in MERS-CoV transmission within 48 h with infections that continued for 14 days post challenge. Conclusions Our finding suggests that the majority of young dromedary camels in Saudi Arabia are seropositive and that naturally infected camels can serve as a challenge model to assess transmission, therapeutics, and vaccine efficacy.http://link.springer.com/article/10.1186/s12985-020-01347-5MERS-CoVDromedary camelsSeroprevalenceSaudi ArabiaVaccine efficacyChallenge model
spellingShingle Naif Khalaf Alharbi
Osman H. Ibrahim
Ali Alhafufi
Samy Kasem
Ali Aldowerij
Raed Albrahim
Ali Abu-obaidah
Ali Alkarar
Faisal Altaib Bayoumi
Ali Mohammed Almansour
Musaad Aldubaib
Hail M. Al-Abdely
Hanan H. Balkhy
Ibrahim Qasim
Challenge infection model for MERS-CoV based on naturally infected camels
Virology Journal
MERS-CoV
Dromedary camels
Seroprevalence
Saudi Arabia
Vaccine efficacy
Challenge model
title Challenge infection model for MERS-CoV based on naturally infected camels
title_full Challenge infection model for MERS-CoV based on naturally infected camels
title_fullStr Challenge infection model for MERS-CoV based on naturally infected camels
title_full_unstemmed Challenge infection model for MERS-CoV based on naturally infected camels
title_short Challenge infection model for MERS-CoV based on naturally infected camels
title_sort challenge infection model for mers cov based on naturally infected camels
topic MERS-CoV
Dromedary camels
Seroprevalence
Saudi Arabia
Vaccine efficacy
Challenge model
url http://link.springer.com/article/10.1186/s12985-020-01347-5
work_keys_str_mv AT naifkhalafalharbi challengeinfectionmodelformerscovbasedonnaturallyinfectedcamels
AT osmanhibrahim challengeinfectionmodelformerscovbasedonnaturallyinfectedcamels
AT alialhafufi challengeinfectionmodelformerscovbasedonnaturallyinfectedcamels
AT samykasem challengeinfectionmodelformerscovbasedonnaturallyinfectedcamels
AT alialdowerij challengeinfectionmodelformerscovbasedonnaturallyinfectedcamels
AT raedalbrahim challengeinfectionmodelformerscovbasedonnaturallyinfectedcamels
AT aliabuobaidah challengeinfectionmodelformerscovbasedonnaturallyinfectedcamels
AT alialkarar challengeinfectionmodelformerscovbasedonnaturallyinfectedcamels
AT faisalaltaibbayoumi challengeinfectionmodelformerscovbasedonnaturallyinfectedcamels
AT alimohammedalmansour challengeinfectionmodelformerscovbasedonnaturallyinfectedcamels
AT musaadaldubaib challengeinfectionmodelformerscovbasedonnaturallyinfectedcamels
AT hailmalabdely challengeinfectionmodelformerscovbasedonnaturallyinfectedcamels
AT hananhbalkhy challengeinfectionmodelformerscovbasedonnaturallyinfectedcamels
AT ibrahimqasim challengeinfectionmodelformerscovbasedonnaturallyinfectedcamels